Why Still Nothing For AMR? EMA Asks PRIME Scheme Applicants

 
• By Neena Brizmohun

The European Medicines Agency wants AMR drug developers to apply for entry on its priority medicine (PRIME) scheme.

Bacterias 3D rendering
The EMA wants applicants for its PRIME scheme to target antimicrobial resistance

More from Europe

More from Geography